Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 30 2014
Print RSS Feed

Search Results for 'Phase II'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

By Gil Roth
Published November 5, 2013
Zerenex trial reaches goals in NDD-CKD patients Read More »
By Gil Roth
Published October 11, 2013
Trial showed no PML cases Read More »
By Gil Roth
Published October 9, 2013
IPT trials in patients with wet AMD and VMT Read More »
Published September 24, 2012
Contractor error associated with bavituximab trial Read More »
Published May 25, 2011
Sixth milestone resulting from 2005 CNS pact Read More »
Published April 15, 2011
Galapagos NV will discontinue its Phase II trial for GLPG0259 in rheumatoid arthritis (RA) following a planned interim analysis that did not support continuing development of the drug for RA. Read More »
Published March 21, 2011
Genentech’s Phase II study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a severe form of skin cancer. Read More »
Published March 15, 2010
Portola Pharmaceuticals and Merck achieved positive results from EXPLORE-Xa, a Phase II dose finding study of investigational oral direct Factor Xa inhibitor betrixaban. Read More »
Can Multivariate Partnerships Streamline Drug Development?
Published June 3, 2014
Quintiles and Biogen Idec enter strategic pact aimed at optimizing Biogen’s clinical development processes Read More »
Will Cell-Based Therapy Shape Biopharma’s Future?
Published June 3, 2014
Pluristem’s CEO, Zami Aberman, compares the state of stem cell research today to where antibodies were 20 years ago. Clinical evidence is key to moving the technology forward, he says. Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On